<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01032343</url>
  </required_header>
  <id_info>
    <org_study_id>AICR 08-0131</org_study_id>
    <secondary_id>UKCRN 6873</secondary_id>
    <nct_id>NCT01032343</nct_id>
  </id_info>
  <brief_title>An Immunonutritional Approach to the Prevention of Skin Cancer</brief_title>
  <official_title>The Effect of Omega-3 Polyunsaturated Fatty Acids on UV-induced Immunosuppression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manchester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Manchester</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Skin cancer incidence continues to rise and ultraviolet radiation (UVR) in sunlight is the&#xD;
      principal cause. Solar UVR can promote cancer development through its ability to suppress the&#xD;
      immune system. The purpose of this study is to determine whether dietary supplementation with&#xD;
      omega-3 polyunsaturated fatty acids can protect human skin from UVR-induced&#xD;
      immunosuppression.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Skin cancer is one of the most common human cancers with a rising incidence and considerable&#xD;
      negative impact on human health. Exposure to ultraviolet radiation (UVR) in sunlight is the&#xD;
      major aetiological factor in skin cancer initiation and progression. Human case-control&#xD;
      studies have reported an inverse relationship between dietary fish or omega-3 polyunsaturated&#xD;
      fatty acid (PUFA) intake and occurrence of non-melanoma skin cancer. Omega-3 PUFA have the&#xD;
      potential to reduce the risk of photocarcinogenesis primarily by their ability to reduce&#xD;
      production of prostaglandin E2 and consequently photoimmunosuppression. To date, no studies&#xD;
      have assessed the impact of omega-3 PUFA on skin photoimmunosuppression in humans.&#xD;
&#xD;
      OBJECTIVE: To examine the potential of dietary omega-3 PUFA to protect against UVR-induced&#xD;
      cutaneous immunosuppression in humans.&#xD;
&#xD;
      STUDY DESIGN: A double-blind randomised controlled nutritional study in 64 healthy human&#xD;
      volunteers with nickel sensitivity. Volunteers will receive 3 months dietary supplementation&#xD;
      with either omega-3 PUFA (n=32) or gelatine (n=32) both provided in identical gelatine&#xD;
      capsules.&#xD;
&#xD;
      The aim is to quantify the influence of omega-3 PUFA on:&#xD;
&#xD;
        1. UVR-induced suppression of clinical contact hypersensitivity (CHS) responses&#xD;
&#xD;
        2. UVR-induced modulation of epidermal Langerhans cell trafficking&#xD;
&#xD;
        3. UVR-induced modulation of levels of immunoregulatory mediators&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Degree of suppression of nickel-induced contact hypersensitivity</measure>
    <time_frame>3 months</time_frame>
    <description>Measurement of the erythema of nickel-induced eczema using a reflectance instrument</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intergroup comparison of cytokine and eicosanoid levels and Langerhans cell numbers</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of susceptibility to photoimmunosuppression in all subjects with their erythrocyte omega-3:omega-6 PUFA ratio</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of susceptibility to photoimmunosuppression with cytokine and eicosanoid levels and Langerhans cell numbers</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Skin Cancer</condition>
  <arm_group>
    <arm_group_label>Omega-3 PUFA capsule</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Gelatine capsule</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Omega-3 PUFA</intervention_name>
    <description>One capsule (4g omega-3 PUFA) daily for 3 months</description>
    <arm_group_label>Omega-3 PUFA capsule</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Gelatine</intervention_name>
    <description>One capsule daily for 3 months</description>
    <arm_group_label>Gelatine capsule</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pre-menopausal females&#xD;
&#xD;
          -  Sun-reactive skin type I / II&#xD;
&#xD;
          -  Reporting allergy to jewellery with nickel content&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of atopy&#xD;
&#xD;
          -  History of skin cancer&#xD;
&#xD;
          -  History of a photosensitivity disorder&#xD;
&#xD;
          -  Sunbathing (including sunbeds) in the last 3 months&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  History of cardiac disease&#xD;
&#xD;
          -  Taking photoactive medicine&#xD;
&#xD;
          -  Not able to eat fish or gelatine&#xD;
&#xD;
          -  Taking fish oil supplements prior to the study&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lesley E Rhodes, MBBS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manchester</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Salford Royal NHS Foundation Trust</name>
      <address>
        <city>Manchester</city>
        <zip>M6 8HD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.staffnet.manchester.ac.uk/volunteering/display/index.htm?id=149716</url>
    <description>Study recruitment information</description>
  </link>
  <results_reference>
    <citation>Pilkington SM, Massey KA, Bennett SP, Al-Aasswad NM, Roshdy K, Gibbs NK, Friedmann PS, Nicolaou A, Rhodes LE. Randomized controlled trial of oral omega-3 PUFA in solar-simulated radiation-induced suppression of human cutaneous immune responses. Am J Clin Nutr. 2013 Mar;97(3):646-52. doi: 10.3945/ajcn.112.049494. Epub 2013 Jan 30.</citation>
    <PMID>23364005</PMID>
  </results_reference>
  <verification_date>August 2013</verification_date>
  <study_first_submitted>December 14, 2009</study_first_submitted>
  <study_first_submitted_qc>December 14, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 15, 2009</study_first_posted>
  <last_update_submitted>August 21, 2013</last_update_submitted>
  <last_update_submitted_qc>August 21, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 22, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Manchester</investigator_affiliation>
    <investigator_full_name>Lesley Rhodes</investigator_full_name>
    <investigator_title>Professor of Experimental Dermatology</investigator_title>
  </responsible_party>
  <keyword>Immunosuppression</keyword>
  <keyword>Ultraviolet radiation</keyword>
  <keyword>Nickel</keyword>
  <keyword>Contact hypersensitivity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

